Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis

BACKGROUND: Few data are available so far on the antibody-mediated immune response to anti-SARS-Cov2 vaccination in people with multiple sclerosis (pwMS) treated with disease-modifying treatments (DMTs), therefore this issue was explored in a real-life cohort of pwMS. MATERIALS AND METHODS: Retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariottini, Alice, Bertozzi, Andrea, Marchi, Leonardo, Di Cristinzi, Maria, Mechi, Claudia, Barilaro, Alessandro, Massacesi, Luca, Repice, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891428/
https://www.ncbi.nlm.nih.gov/pubmed/35239006
http://dx.doi.org/10.1007/s00415-022-11003-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891428/
https://www.ncbi.nlm.nih.gov/pubmed/35239006
http://dx.doi.org/10.1007/s00415-022-11003-3

Ejemplares similares